Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5644 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 55 56 57

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Bioserv AG–NONE: investment, 200304– bankruptcy filed Local Court Rostock 2003-04-11
BMS–Lonza: biologics contract manufacturing, 2003– supply of commercially marketed biological drug by Lonza 2003-01-01
BMS–Lonza: biologics contract manufacturing, 201410– expansion supply €na incl 2nd commercially marketed biological drug by Lonza 2003-01-01
Chandler Instruments–AMETEK: investment, 2003 acquisition of Chandler Instruments by AMETEK 2003-01-01
Inula–Metrohm: investment, 2003 acquisition 2003-01-01
ETG GmbH–Analytik Jena: investment, 2002 acquisition of 20% share by Analytik Jena AG 2002-01-01
Grabner Instruments–Chandler Instruments: investment, 2002 acquisition of Grabner by Chandler 2002-01-01
NatLifE 2020 project–BRAIN: food biotechnology, 2011– partner + coordinator NatLifE 2020 alliance with 22 partners 2001-11-01
Cardion–ROI Verwaltungsgesellschaft: investment, 200107 existent 2001-07-08
Kourion Therapeutics–ROI Verwaltungsgesellschaft: investment, 200107 existent 2001-07-08
Biocentric–Hain Lifescience: molecular diagnostics, 2001– exclusive distributor of Hain products in France 2001-01-01
Glycotope–Eckert Wagniskapital: investment, 2001 founding investor Eckert Wagniskapital und Frühphasenfinanzierung GmbH 2001-01-01
International Univ Bremen–Bremen (govt): credit, 2003 loan guarantee for €50m given by Federal State of Bremen 2001-01-01
International Univ Bremen–Bremen (govt): grant, 2001 start financing support €230m from Federal State of Bremen 2001-01-01
Selexis–SEVERAL: investment, 2001 seed financing CHF100k 2001-01-01
CLIB 2021 Cluster–Protagen: industrial biotechnology, 2010 collab Protagen is project partner of CLIB 2021 2000-01-01
OncoTyrol project–Protagen: cancer diagnostics, 2010 collab existent Protagen is project partner of OncoTyrol 2000-01-01
Evolva–SEVERAL: investment, 200910 financing round Series B 1st tranche CHF28m 1999-10-22
Evolva–SEVERAL: investment, 200912 financing round Series B 2nd tranche CHF16m incl new + lead investor Entrepreneurs Fund 1999-10-22
Evolva–Ventureast: investment, 200912– commitment to invest CHF5m in Evolva Biotech Pvt Ltd by Ventureast Trustee Co Pvt Ltd 1999-10-22
Boehringer Mannheim–Roche: investment, 1998 acquisition by Roche 1998-01-01
Dima–Meikang Biotech: rapid diagnostics, 1998– distribution of lateral flow quick tests in Europe by Dima GmbH 1998-01-01
Eurofins–SEVERAL: investment, 199710 IPO 1997-10-24
Novartis–Yoshitomi Pharmaceutical: fingolimod, 199709– license ww for immunosuppressant FTY720 1997-09-24
Hoechst–Clariant: investment, 1997 acquisition of Hoechst Speciality Chemical Business by Clariant 1997-01-01
Techlab–DataApex: chromatography s/w, 1995– distribution of Clarity s/w by Techlab GmbH 1995-01-01
Brechbühler–Phenomenex: chromatography consumables, 1991–201708 distribution in Switzerland by Brechbühler TERMINATED 9/17 1991-01-01
Roche–Sigma-Aldrich: investment, 1989 acquisition of Fluka from Roche + Ciba-Geigy by Sigma-Aldrich 1989-01-01
Columbus Pharmaceutical–Boehringer: investment, 1978 acquistion by Boehringer + renamed Roxane Laboratories Inc 1978-01-01
Roche–Hitachi: immunoassay analyser, 1978– collab strategic alliance developm + production of instruments + automated workflows 1978-01-01
Agilent–Univ Duisburg-Essen: analytical technology, 201804– collab with new Agilent sponsored Teaching + Research Center for Separation (TRC) at UDE
AiCuris–SEVERAL: investment, 201004 financing round Series B €55m from existing investors led by Santo Holding
Biotest–Merck (DE): investment, 201103 acquisition of Biotest microbiology business incl heipha Dr Müller GmbH + Hycon by Merck
Cellestia Biotech–SEVERAL: investment, 201701 seed financing round Series C CHF5.2m from Sotio/PPF Group + private investors
Cellestia Biotech–SEVERAL: investment, <2017 seed financing round Series A CHF0.5m
Cellestia Biotech–SEVERAL: investment, <2017 seed financing round Series B CHF2.3m
Eckert & Ziegler–Eckert Wagniskapital: investment, 19?? founding investor Eckert Wagniskapital und Frühphasenfinanzierung GmbH
Greenovation–Zukunftsfonds Heilbronn: investment, 201105 existent Greenovation listed as part of portfolio
Mind NRG–Minerva Neurosciences: investment, before 202008 acquisition of Mind NRG (CH) by Minerva Neurosciences
OTHER–Novartis: investment, 201401 acquisition of biologics manufacturing faciltiy in Longmont CO by AveXis
R-Biopharm–EuroProxima: research antibodies, 201710 acquisition of research antibody line from EuroProxima BV by Progen Biotechnik GmbH
SimplicityBio–TATAA Biocenter: biomarker services, 201610– collab product integration to offer complete biomarker solutions
Sprout Pharmaceuticals–Boehringer: flibanserin, <201303 acquisition of flibanserin from Boehringer Ingelheim
ZIM Plant Technology–Yara: investment, 201311–201401 acquisition by Yara
next pagenext page 1 2 3 ... 55 56 57


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [iito] Made Without Love 650x80px

» top